Due to the large clinical and genetic variabilities observed [31], and the absence of strict genotype-phenotype correlations, we suggest that in the clinical setting it is insufficient to test individuals with HSP for only known SPAST mutations, and in the case of negative results, additional loci should be sequenced in case other HSP mutations may be present. Here, SPAST is linked to hereditary spastic paraplegia.